Literature DB >> 3964758

Comparative esophageal and anorectal motility in scleroderma.

J Hamel-Roy, G Devroede, P Arhan, L Tétreault, A Duranceau, H A Ménard.   

Abstract

Esophageal and anorectal pressures were recorded in 26 patients (4 men and 22 women) with scleroderma. Eleven patients suffered from a localized form of the disease and 15 from progressive systemic sclerosis. The latter only had marked functional abnormalities in esophageal and anorectal motility. Mean resting pressure at the lower esophageal sphincter of patients with progressive system sclerosis and controls was, respectively, 6 +/- 2 and 25 +/- 1 mmHg (p less than 0.001); mean closing pressure was 5 +/- 5 and 48 +/- 3 mmHg (p less than 0.001); coordination of opening the lower esophageal sphincter with the oncoming contraction in the distal esophagus was 0% and 68% +/- 5% (p less than 0.001); and relaxation (fall of the lower esophageal sphincter pressure to resting levels in the stomach) was 18% +/- 12% and 98% +/- 1% (p less than 0.001). The rectoanal inhibitory reflex was of lesser amplitude than normal in 74% of patients with progressive system sclerosis and was absent in 13%. Quantitative analysis demonstrated a significant reduction in response to rectal distention with 20 or more ml of air (p less than 0.001). There was a correlation between the amplitude of the lower esophageal sphincter relaxation and the amplitude of the rectoanal inhibitory reflex in response to rectal distention with 30-50 ml of air (p less than 0.05 to p less than 0.025). Our data show that in systemic sclerosis, anorectal motility is as frequently abnormal as esophageal motility.

Entities:  

Mesh:

Year:  1985        PMID: 3964758     DOI: 10.1016/s0016-5085(85)80124-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Investigation of anal function in patients with systemic sclerosis.

Authors:  A L Herrick; J D Barlow; A Bowden; N Williams; A R Hobson; M Irving; M I Jayson
Journal:  Ann Rheum Dis       Date:  1996-06       Impact factor: 19.103

2.  Gastrobiliary motility after liquid fatty meal in progressive systemic sclerosis. A sonographic study.

Authors:  B Wedmann; M Wegener; R J Adamek; S el Gammal
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

3.  Oesophageal manometry in early and definite systemic sclerosis.

Authors:  Paolo Airò; Domenico Della Casa; Elisabetta Danieli; Guido Missale; Roberto Cattaneo; Renzo Cestari
Journal:  Clin Rheumatol       Date:  2004-12-09       Impact factor: 2.980

4.  Work-up of the constipated patient.

Authors:  Elisa H Birnbaum
Journal:  Clin Colon Rectal Surg       Date:  2008-11

5.  Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells.

Authors:  Jagmohan Singh; Vaibhav Mehendiratta; Francesco Del Galdo; Sergio A Jimenez; Sidney Cohen; Anthony J DiMarino; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

6.  Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.

Authors:  G N Verne; E Y Eaker; E Hardy; C A Sninsky
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

7.  Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis.

Authors:  G Basilisco; R Barbera; M Vanoli; P Bianchi
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

8.  Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis.

Authors:  J L Madsen; L Hendel
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

9.  Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence.

Authors:  A F Engel; M A Kamm; I C Talbot
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

Review 10.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.